XCel Brands (XELB) director reports restricted stock and option awards
Rhea-AI Filing Summary
Deborah Weinswig, a director of XCel Brands, Inc., reported receiving new equity awards in the company.
On 12/03/2025 she was granted 6,800 shares of restricted common stock at $0, increasing her direct holdings to 13,600 shares. These restricted shares are scheduled to vest on March 31, 2026, and she may extend the vesting date in six month increments at her discretion.
She was also granted stock options covering 21,500 shares of common stock at an exercise price of $0.94 per share, exercisable from 12/03/2025 and expiring on 12/03/2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 21,500 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 6,800 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents shares of restricted stock awarded pursuant to a restricted stock agreement, which vests on March 31, 2026, provided that the reporting person may extend the vesting date as to all or a portion of the shares, one or more times, in six month increments, at his sole discretion.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did XELB director Deborah Weinswig report?
Deborah Weinswig reported acquiring 6,800 shares of restricted common stock at $0 and receiving 21,500 stock options at an exercise price of $0.94 on 12/03/2025.
What are the key terms of the XCel Brands stock options granted to Deborah Weinswig?
She received 21,500 stock options with an exercise price of $0.94 per share, exercisable from 12/03/2025 and expiring on 12/03/2030. Each option relates to one share of common stock.
Is this XCel Brands Form 4 filed for one reporting person or a group?
The form indicates it is filed by one reporting person, covering the holdings and transactions of Deborah Weinswig only.